Ongoing trials in HIV protease inhibitors.

  • Jorge A. Tavel
  • Published 2000 in Expert opinion on investigational drugs
The development of antiretrovirals has led to a revolution in the care of patients infected with HIV. What was once a uniformly fatal syndrome has become a more treatable, chronic, infectious disease. Central to this revolution have been the protease inhibitors, a class of drugs with potent antiretroviral activity. The first member of this class was… (More)